OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathogenesis of the Tauopathies
Jürgen Götz, Glenda M. Halliday, Rebecca M. Nisbet
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 14, Iss. 1, pp. 239-261
Closed Access | Times Cited: 225

Showing 1-25 of 225 citing articles:

Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 801

Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research
Christina M. Moloney, Val J. Lowe, Melissa E. Murray
Alzheimer s & Dementia (2021) Vol. 17, Iss. 9, pp. 1554-1574
Open Access | Times Cited: 195

Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?
Helena Targa Dias Anastacio, Natalie Matosin, Lezanne Ooi
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 193

Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187

Role of tau protein in Alzheimer's disease: The prime pathological player
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 1599-1617
Closed Access | Times Cited: 178

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 162

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 153

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease
Jack M. Webster, April L. Darling, Vladimir N. Uversky, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 146

Tau strains shape disease
Jaime Vaquer‐Alicea, Marc I. Diamond, Łukasz A. Joachimiak
Acta Neuropathologica (2021) Vol. 142, Iss. 1, pp. 57-71
Open Access | Times Cited: 115

Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases
Dan Li, Cong Liu
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 9, pp. 523-534
Closed Access | Times Cited: 75

TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Z. Zhang, Dilshan S. Harischandra, Ruifang Wang, et al.
Science (2023) Vol. 381, Iss. 6656
Open Access | Times Cited: 56

Cellular and pathological functions of tau
C Bravo, Sarah Naguib, Li Gan
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 845-864
Closed Access | Times Cited: 36

Human iPSC 4R tauopathy model uncovers modifiers of tau propagation
C Bravo, Alice Maria Giani, Jesus Madero-Perez, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2446-2464.e22
Open Access | Times Cited: 26

The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 23

Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer’s disease
Katrien Princen, Tom Van Dooren, Marit van Gorsel, et al.
Science (2024) Vol. 384, Iss. 6699
Open Access | Times Cited: 17

Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Daniela Dias, Renato Socodato
Biomedicines (2025) Vol. 13, Iss. 2, pp. 279-279
Open Access | Times Cited: 2

Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons
M. Catarina Silva, Ghata Nandi, Sharon Tentarelli, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 127

An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Keliang Pang, Richeng Jiang, Wei Zhang, et al.
Cell Research (2021) Vol. 32, Iss. 2, pp. 157-175
Open Access | Times Cited: 87

Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2020) Vol. 177, pp. 113945-113945
Closed Access | Times Cited: 85

Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
Shanya Jiang, Kiran Bhaskar
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 84

Insights into Disease-Associated Tau Impact on Mitochondria
Leonora Szabo, Anne Eckert, Amandine Grimm
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6344-6344
Open Access | Times Cited: 72

NLRP3 inflammasome in neurodegenerative disease
Faith L. Anderson, Karl Biggs, Brynn E. Rankin, et al.
Translational research (2022) Vol. 252, pp. 21-33
Open Access | Times Cited: 67

Classification of diseases with accumulation of Tau protein
Gábor G. Kovács, Bernardino Ghetti, Michel Goedert
Neuropathology and Applied Neurobiology (2022) Vol. 48, Iss. 3
Open Access | Times Cited: 60

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
Andrea Corsi, Cristina Bombieri, Maria Teresa Valenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15383-15383
Open Access | Times Cited: 48

Page 1 - Next Page

Scroll to top